Are there fake Ozempic and Mounjaro pens?
Yes, and regulators in Europe, the US and Brazil have said so. In June 2024 the World Health Organization issued Medical Product Alert N°2/2024 on three falsified batches of semaglutide (sold as Ozempic), found in Brazil and the UK in October 2023 and in the US in December 2023. It named the risks as incorrect dosage, contamination with harmful substances and unknown or substituted ingredients.
The European Medicines Agency reported falsified 1 mg pens at wholesalers in the EU and UK in October 2023. The US FDA says counterfeit Ozempic has been identified in the US supply and may hold the wrong ingredients, too little, too much or none of the active ingredient, or harmful ones.
Tirzepatide (sold as Mounjaro) has been copied too. In April 2026 more than 260 suspected counterfeit pens were found in a vehicle in Haryana, India, with two arrests, and in July 2026 Brazil's regulator ordered the seizure of counterfeit lots after the manufacturer found units that differed from the originals (a news report, not the regulator's own notice).
Is fake Mounjaro or Ozempic a problem in Malaysia?
No source read for this article reports a Malaysian seizure of counterfeit Mounjaro or Ozempic, and none is claimed here. What the Ministry of Health did report on 28 August 2026 is enforcement on weight-loss products generally: 65 complaints and 30 raids between January and July 2026, 17 of them on online sales, with RM477,142 seized. Those concern unregistered products, which are a related risk. Reta or Mounjaro covers one such product.
An unregistered pen and a copied pen share one weakness: nobody independent has checked what is inside. The checks below are worth doing before the first injection, and not after a problem.
What should I check first?
Start with who is supplying it. In Malaysia semaglutide and tirzepatide are prescription medicines, supplied by a registered doctor to a patient they have assessed or by a licensed pharmacist filling a prescription. Where to get these medicines legally in Malaysia sets out why the prescription matters.
The FDA gives red flags for a seller: no screening by a prescriber, suspicious pricing and damaged packaging. In the Indian case the pens were sold at 27% below the genuine price. A price far below the pharmacy is information, not luck.
Never buy from social media accounts, chat groups or "slimming" sellers. That is where a prescription is skipped, and with it the pharmacy that stands between the maker and the patient. The EMA found no evidence that falsified pens reached patients through legitimate pharmacies.
How do I check the registration number?
A registered medicine in Malaysia carries a MAL registration number on its carton. Search that number, or the product name, on the NPRA QUEST3+ product search under pharmaceutical products. The Ministry of Health also advises checking the FarmaTag hologram through FarmaChecker in the MyUbat app, and a pharmacist can do this. The step-by-step is in how to check if a product is KKM approved.
Be clear about what this proves. A number on the register shows the product is registered. It does not show the box in your hand is genuine. The EMA found fakes carrying batch numbers, 2D barcodes and serial numbers copied from genuine packs, and the serial numbers only showed as inactive when scanned. WHO also lists a batch number that is genuine on a falsified product. That is why the source matters as much as the number.
What do the pen and the box tell me?
Some things can be seen, though looks alone are not proof. WHO lists lot and serial numbers that do not match the manufacturer's records, a dose scale that extends when you set a dose, poor label quality and adhesion, and spelling errors on the packaging. In the Indian case officials noted differences in font size and label details, and the pens had not been kept in temperature-controlled storage.
Compare with the manufacturer's or regulator's published pictures and the patient leaflet, not with images the seller sends. The EMA says appearance differs between falsified and original pens and points to images published by the German medicines agency. Treat a mismatch as a reason to stop. Treat a match as the beginning of the check, not the end.
What should I do if I think I have a fake?
Stop using it. WHO advises not to use affected products and to seek medical advice if you have used one, and the EMA advises returning a suspicious pen to the pharmacy. Keep the pen, the box and any receipts or messages, because they help a regulator trace the source. What you can still check about what you were given sets out what to keep and which signs need a doctor the same day.
See a doctor, especially if you feel unwell. Then report it. NPRA's reporting page says unregistered or fake products go to the Ministry of Health complaint system (SisPAA, moh.spab.gov.my), while a side effect of a registered medicine goes through NPRA's ConSERF form. NPRA's telephone is +603 7883 5400.
Why is self-dosing a separate risk?
A genuine pen still carries risk when it is used without a prescriber. The licensed medicines start low and rise in steps, and splitting a pen or measuring a dose from a vial is outside any licensed regimen. Can I microdose Mounjaro? explains why.
The reason the prescription matters is the review that comes with it. At The Retreat Clinic, Dr Ong prescribes these medicines and reviews patients weekly at the start, tailoring the dose. That oversight is the part a pen from a stranger cannot supply, whether it is genuine or not. The clinic's weight management page describes the assessment.
